These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 23486643

  • 1. Clinical effects of gemifloxacin on the delay of tuberculosis treatment.
    Kim SY, Yim JJ, Park JS, Park SS, Heo EY, Lee CH, Chung HS, Kim DK.
    J Korean Med Sci; 2013 Mar; 28(3):378-82. PubMed ID: 23486643
    [Abstract] [Full Text] [Related]

  • 2. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK, Triller DM, Yong CS, Lodise TP.
    Ann Pharmacother; 2004 Mar; 38(7-8):1226-35. PubMed ID: 15187209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Zhang L, Wang R, Falagas ME, Chen LA, Liu YN.
    Chin Med J (Engl); 2012 Feb; 125(4):687-95. PubMed ID: 22490497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.
    Tseng YT, Chuang YC, Shu CC, Hung CC, Hsu CF, Wang JY.
    Crit Care; 2012 Oct 25; 16(5):R207. PubMed ID: 23098258
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infections.
    File TM, Tillotson GS.
    Expert Rev Anti Infect Ther; 2004 Dec 25; 2(6):831-43. PubMed ID: 15566328
    [Abstract] [Full Text] [Related]

  • 14. Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice.
    Bast DJ, Dresser L, Duncan CL, Walker SE, Mandell LA, Low DE, de Azavedo JC.
    J Chemother; 2006 Dec 25; 18(6):634-40. PubMed ID: 17267342
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P, File T, Feldman C.
    Respir Med; 2004 Aug 25; 98(8):708-20. PubMed ID: 15303634
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
    File TM, Schlemmer B, Garau J, Cupo M, Young C, 049 Clinical Study Group.
    J Antimicrob Chemother; 2001 Jul 25; 48(1):67-74. PubMed ID: 11474633
    [Abstract] [Full Text] [Related]

  • 20. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM, Mandell LA, Tillotson G, Kostov K, Georgiev O.
    J Antimicrob Chemother; 2007 Jul 25; 60(1):112-20. PubMed ID: 17537866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.